NCT07831525

Brief Summary

Transcranial modulation of the corticospinal sensorimotor pathway is a promising approach in neuroscientic functions. Among the techniques used, transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS) and the application of random noise current stand out. Objective: To compare the e stimulus, in the EEG frequency bands, on Motor Evoked Potentials (MEP) and on the functional activation of the motor cortex, assessed by Functional Near Infrared Spectroscopy (fNIRS) and pain measurements in healthy subjects subjected to a standardized algogenic stimulus. Subjects and Method: This is a randomized, double-blind, controlled and crossover clinical trial, involving the inclusion of 14 healthy male subjects, with complete secondary education, aged between 18 and 40. years. Participants will be randomized to receive Transcranial Direct Current Stimulation (tDCS), (2) Transcranial Alternating Current Stimulation (tACs), (3) Random Noise Current, (4) Simulated Stimulation Session and (5) Rest Session. Experimental conditions will take place in a standard, quiet and bright room. Assessments will include Motor Evoked Potential, Heat Pain Threshold, Motor Area Activation through metabolic activation measured by fNIRS and analysis of EEG frequency waves. After the baseline assessment, participants will undergo a session of transcranial stimulation, followed by an algogenic stimulus with water at zero degrees, immersion of the dominant hand for 1 minute, with rest intervals of 3 minutes between each of the four serial stimuli. After this stimulus session, outcome measurements will be carried out. Expected results: This clinical trial is expected to provide insights into how tDCS, tACs and random stimulation in to an algogenic stimulus. The results may contribute to the development of therapeutic or neuromodulation strategies in clinical conditions where the regulation of the cortico-spinal sensorimotor pathway is relevant.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
2mo left

Started Jul 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress49%
Jul 2026Dec 2026

First Submitted

Initial submission to the registry

January 13, 2026

Completed
6 months until next milestone

Study Start

First participant enrolled

July 15, 2026

Completed
2 months until next milestone

First Posted

Study publicly available on registry

September 21, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 26, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 26, 2026

Last Updated

September 21, 2026

Status Verified

September 1, 2026

Enrollment Period

3 months

First QC Date

January 13, 2026

Last Update Submit

September 16, 2026

Conditions

Keywords

tDCStACSRNSQSTCPM-test

Outcome Measures

Primary Outcomes (1)

  • Resting-State EEG Power Spectra Across Frequency Bands (Delta, Theta, Alpha, Beta 1, Beta 2, and Gamma)

    Electroencephalography (EEG) will be used to quantify neuronal activity through quantitative EEG (qEEG) analysis. Resting-state EEG power spectra will be analyzed across delta, theta, alpha, beta, and gamma frequency bands, reflecting synchronized neuronal oscillations. EEG data will be recorded using a 20-electrode montage according to the international 10-20 system during an 8-minute resting-state paradigm with alternating eyes-open and eyes-closed conditions. Cortical source localization will be performed using standardized Low-Resolution Brain Electromagnetic Tomography (sLORETA).

    Immediately before and immediately after the intervention.

Secondary Outcomes (5)

  • Corticospinal Excitability

    Immediately before and immediately after the intervention.

  • Motor Cortex Functional Connectivity

    Immediately before and immediately after the intervention.

  • Heat Pain Threshold

    Immediately before and immediately after the intervention.

  • Function of the Descending Pain Inhibitory System

    Immediately before and immediately after the intervention.

  • Cold Pressor Test Pain Tolerance

    Immediately before and immediately after the intervention.

Study Arms (5)

Transcranial Direct Current Stimulation (tDCS) over motor area (M1)

ACTIVE COMPARATOR

Participants receive active transcranial direct current stimulation over the primary motor cortex (M1) during the intervention sessions.

Device: Transcranial Direct Current Stimulation

Transcranial Alternating Current Stimulation (tACS) over M1

ACTIVE COMPARATOR

Participants receive active transcranial alternating current stimulation over the primary motor cortex (M1) during the intervention sessions.

Device: Transcranial Alternating Current Stimulation

Transcranial Random Noise Stimulation (tRNS) over M1

ACTIVE COMPARATOR

Participants receive active transcranial random noise stimulation over the primary motor cortex (M1) during the intervention sessions.

Device: Transcranial Random Noise Stimulation (tRNS)

Sham Stimulation

SHAM COMPARATOR

Participants undergo sham stimulation, experiencing the same setup as active stimulation without actual current delivery.

Device: Sham Stimulation

Rest State

NO INTERVENTION

Participants remain seated with their eyes open for 20 minutes during the rest session, without performing any other task.

Interventions

Single session of active gamma transcranial alternating current stimulation delivered for 30 minutes using a battery-powered external stimulator. Stimulation is applied through two sponge electrodes (5 × 7 cm) mounted on a neoprene cap. The stimulation frequency is 40 Hz, based on previous gamma-band transcranial alternating current stimulation (tACS) studies. The anode is positioned at C3 (left primary motor cortex, M1), and the cathode over the ipsilateral clavicular region.

Also known as: tACS
Transcranial Alternating Current Stimulation (tACS) over M1

Stimulation is delivered using two sponge electrodes (5 × 7 cm) mounted on a neoprene cap. The electrodes are positioned on the scalp according to the international 10-20 system. The anode is placed at position C3 (left primary motor cortex, M1) and the cathode over the ipsilateral clavicular region. The sinusoidal current intensity per channel ranges from ±2 mA. The session duration is 20 minutes.

Also known as: tDCS
Transcranial Direct Current Stimulation (tDCS) over motor area (M1)

Stimulation is delivered using two sponge electrodes mounted on a neoprene cap. The anode is positioned at C3 (left primary motor cortex, M1), and the cathode over the ipsilateral clavicular region. A random current level is generated for each sample at a sampling rate of 1280 samples per second. The random values are normally distributed, following a bell-shaped probability density function. The noise signal contains all frequencies up to half the sampling rate (maximum 640 Hz) and has no DC offset.

Also known as: tRNS
Transcranial Random Noise Stimulation (tRNS) over M1

During the sham stimulation session, the tDCS device ramps up the current to 2 mA over 30 seconds and then is immediately turned off. This procedure mimics the sensations of active stimulation without delivering therapeutic current for the remainder of the session.

Also known as: sham
Sham Stimulation

Eligibility Criteria

Age18 Years - 45 Years
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsSelf-identified healthy adult men
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy male subjects aged 18-45 years, with at least a high school diploma, and not engaged in night-shift work.

You may not qualify if:

  • Contraindications to transcranial stimulation include implanted medical devices in the brain, cardiac pacemakers, and cochlear implants.
  • Current use of psychotropic medications.
  • History of alcohol or substance abuse within the past 6 months.
  • Neurological disorders, history of traumatic brain injury, or prior neurosurgery.
  • Beck Depression Inventory-II (BDI-II) score \>13.
  • Self-Reporting Questionnaire (SRQ) score \>7.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital de Clinicas de Porto Alegre

Porto Alegre, Rio Grande do Sul, Brazil

Location

MeSH Terms

Interventions

Transcranial Direct Current Stimulation

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 13, 2026

First Posted

September 21, 2026

Study Start

July 15, 2026

Primary Completion (Estimated)

October 26, 2026

Study Completion (Estimated)

December 26, 2026

Last Updated

September 21, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will share

Data will be available upon request at wcaumo@hcpa.edu.br after 6 months of publication.

Locations